A mouse model of adult-onset anaemia due to erythropoietin deficiency

Nature Communications

Volumn 4, Issue , 2013, Pages

  Yamazaki, Shun ^a   Souma, Tomokazu ^a   Hirano, Ikuo ^a   Pan, Xiaoqing ^a   Minegishi, Naoko ^a   Suzuki, Norio ^a   Yamamoto, Masayuki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADM PROTEIN; ANTIANEMIC AGENT; CD71 ANTIGEN; CISH PROTEIN; COLLAGENASE 3; COMPLEMENTARY DNA; CRE RECOMBINASE; ENO2 PROTEIN; ERYTHROPOIETIN; GLUCOSE TRANSPORTER 3; GREEN FLUORESCENT PROTEIN; GROWTH DIFFERENTIATION FACTOR 3; NEUTRALIZING ANTIBODY; PODXL PROTEIN; PROTEIN; PROTEIN KINASE PIM 1; RECOMBINANT ERYTHROPOIETIN; TFRC PROTEIN; TRANSCRIPTION FACTOR EGR 1; UNCLASSIFIED DRUG; INTEGRASE; MESSENGER RNA;

3' UNTRANSLATED REGION; ADULT; ADULT ONSET ANEMIA; AGE; ALLELE; ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMEGALY; CELL LINEAGE; CELL MATURATION; CONTROLLED STUDY; EMBRYO; ERYTHROBLAST; ERYTHROCYTE; ERYTHROPOIESIS; ERYTHROPOIETIN DEFICIENCY; EXTRACELLULAR MATRIX; FEMALE; FETUS LIVER; FIBROBLAST; FLOW CYTOMETRY; GENE DELETION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART OUTPUT; HEMATOPOIETIC CELL; HISTOLOGY; HORMONE DEFICIENCY; KIDNEY; KIDNEY CORTEX; LIVER CELL; MALE; MOUSE; NONHUMAN; NORMOCHROMIC NORMOCYTIC ANEMIA; PHLEBOTOMY; QUANTITATIVE ANALYSIS; RETICULOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLENOMEGALY; TRANSGENE; UPREGULATION; AGING; ANIMAL; BONE MARROW; CHRONIC DISEASE; DISEASE MODEL; EMBRYO DEATH; GENE EXPRESSION REGULATION; GENETICS; HEMATOPOIESIS; HUMAN; KNOCKOUT MOUSE; LIVER; METABOLISM; ONSET AGE; PATHOLOGY; STAINING; DEFICIENCY;

MUS;

AGE OF ONSET; AGING; ALLELES; ANEMIA; ANIMALS; BONE MARROW; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; EMBRYO LOSS; ERYTHROBLASTS; ERYTHROPOIETIN; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; HEMATOPOIESIS; HUMANS; INTEGRASES; KIDNEY; LIVER; MICE; MICE, KNOCKOUT; RNA, MESSENGER; STAINING AND LABELING; TRANSGENES;

EID: 84890195204     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2950     Document Type: Article

References (58)

1. Koury, M. J. Erythropoietin: the story of hypoxia and a finely regulated hematopoietic hormone. Exp. Hematol. 33, 1263-1270 (2005).
2. Richmond, T. D., Chohan, M. & Barber, D. L. Turning cells red: signal transduction mediated by erythropoietin. Trends. Cell. Biol. 15, 146-155 (2005).
3. Zanjani, E. D., Ascensao, J. L., McGlave, P. B., Banisadre, M. & Ash, R. C. Studies on the liver to kidney switch of erythropoietin production. J. Clin. Invest. 67, 1183-1188 (1981).
4. Dame, C. et al. Erythropoietin mRNA expression in human fetal and neonatal tissue. Blood 92, 3218-3225 (1998).
5. Suzuki, N. et al. Specific contribution of the erythropoietin gene 3′ enhancer to hepatic erythropoiesis after late embryonic stages. Mol. Cell. Biol. 31, 3896-3905 (2011).
6. Pan, X. et al. Isolation and characterization of renal erythropoietin-producing cells from genetically produced anemia mice. PLoS One 6, e25839 (2011).
7. Fandrey, J. Oxygen-dependent and tissue-specific regulation of erythropoietin gene expression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R977-R988 (2004).
8. Ebert, B. L. & Bunn, H. F. Regulation of the erythropoietin gene. Blood 94, 1864-1877 (1999).
9. Semenza, G. L., Dureza, R. C., Traystman, M. D., Gearhart, J. D. & Antonarakis, S. E. Human erythropoietin gene expression in transgenic mice: multiple transcription initiation sites and cis-acting regulatory elements. Mol. Cell. Biol. 10, 930-938 (1990).
10. Semenza, G. L. & Wang, G. L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12, 5447-5454 (1992).
11. Rankin, E. B. et al. Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J. Clin. Invest. 117, 1068-1077 (2007).
12. Madan, A., Lin, C., Hatch, S. L. & Curtin, P. T. Regulated basal, inducible, and tissue-specific human erythropoietin gene expression in transgenic mice requires multiple cis DNA sequences. Blood 85, 2735-2741 (1995).
13. Semenza, G. L., Koury, S. T., Nejfelt, M. K., Gearhart, J. D. & Antonarakis, S. E. Cell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice. Proc. Natl Acad. Sci. USA 88, 8725-8729 (1991).
14. Obara, N. et al. Repression via the GATA box is essential for tissue-specific erythropoietin gene expression. Blood 111, 5223-5232 (2008).
15. Maxwell, P. H. et al. Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney. Int. 44, 1149-1162 (1993).
16. Bachmann, S., Le Hir, M. & Eckardt, K. U. Co-localization of erythropoietin mRNA and ecto-5′-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin. J. Histochem. Cytochem. 41, 335-341 (1993).
17. Suzuki, N., Obara, N. & Yamamoto, M. Use of gene-manipulated mice in the study of erythropoietin gene expression. Methods Enzymol. 435, 157-177 (2007).
18. Koury, S. T., Koury, M. J., Bondurant, M. C., Caro, J. & Graber, S. E. Quantitation of erythropoietin-producing cells in kidneys of mice by in situ hybridization: correlation with hematocrit, renal erythropoietin mRNA, and serum erythropoietin concentration. Blood 74, 645-651 (1989).
19. Eckardt, K. U. et al. Distribution of erythropoietin producing cells in rat kidneys during hypoxic hypoxia. Kidney. Int. 43, 815-823 (1993).
20. Jelkmann, W. Erythropoietin after a century of research: younger than ever. Eur. J. Haematol. 78, 183-205 (2007).
21. Fisher, J. W. Landmark advances in the development of erythropoietin. Exp. Biol. Med. 235, 1398-1411 (2010).
22. Elliott, S. Erythropoiesis-stimulating agents. Cancer Treat. Res. 157, 55-74 (2011).
23. Wu, H., Liu, X., Jaenisch, R. & Lodish, H. F. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83, 59-67 (1995).
24. Lin, C. S., Lim, S. K., D'Agati, V. & Costantini, F. Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. Genes. Dev. 10, 154-164 (1996).
25. Zeigler, B. M., Vajdos, J., Qin, W., Loverro, L. & Niss, K. A mouse model for an erythropoietin-deficiency anemia. Dis. Model. Mech. 3, 763-772 (2010).
26. Gruber, M. et al. Acute postnatal ablation of Hif-2α results in anemia. Proc. Natl Acad. Sci. USA 104, 2301-2306 (2007).
27. Dame, C., Juul, S. E. & Christensen, R. D. The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential. Biol. Neonate. 79, 228-235 (2001).
28. Binley, K. et al. Long-term reversal of chronic anemia using a hypoxiaregulated erythropoietin gene therapy. Blood 100, 2406-2413 (2002).
29. Suzuki, M. et al. Real-time monitoring of stress erythropoiesis in vivo using Gata1 and beta-globin LCR luciferase transgenic mice. Blood 108, 726-733 (2006).
30. Ou, L. C., Kim, D., Layton, W. M. & Smith, R. P. Splenic erythropoiesis in polycythemic response of the rat to high-altitude exposure. J. Appl. Physiol. 48, 857-861 (1980).
31. Socolovsky, M. et al. Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. Blood 98, 3261-3273 (2001).
32. Suzuki, N. et al. Identification and characterization of 2 types of erythroid progenitors that express GATA-1 at distinct levels. Blood 102, 3575-3583 (2003).
33. Du Roure, C. et al. Correction of severe anaemia using immuno-regulated gene therapy is achieved by restoring the early erythroblast compartment. Br. J. Haematol. 132, 608-614 (2006).
34. Sathyanarayana, P. et al. Erythropoietin modulation of podocalyxin and a proposed erythroblast niche. Blood 110, 509-518 (2007).
35. Sivertsen, E. A. et al. PI3K/Akt-dependent Epo-induced signalling and target genes in human early erythroid progenitor cells. Br. J. Haematol. 135, 117-128 (2006).
36. Eshghi, S., Vogelezang, M. G., Hynes, R. O., Griffith, L. G. & Lodish, H. F. Alpha4beta1 integrin and erythropoietin mediate temporally distinct steps in erythropoiesis: integrins in red cell development. J. Cell. Biol. 177, 871-880 (2007).
37. Ulyanova, T., Jiang, Y., Padilla, S., Nakamoto, B. & Papayannopoulou, T. Combinatorial and distinct roles of a5 and a4 integrins in stress erythropoiesis in mice. Blood 117, 975-985 (2011).
38. Huynh, H. H. et al. IGF binding protein 2 supports the survival and cycling of hematopoietic stem cells. Blood 118, 3236-3243 (2011).
39. Stickens, D. et al. Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development 131, 5883-5895 (2004).
40. Singbrant, S. et al. Erythropoietin couples erythropoiesis, B-lymphopoiesis, and bone homeostasis within the bone marrow microenvironment. Blood 117, 5631-5642 (2011).
41. Asada, N. et al. Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice. J. Clin. Invest. 121, 3981-3990 (2011).
42. Kaissling, B., Hegyi, I., Loffing, J. & Le Hir, M. Morphology of interstitial cells in the healthy kidney. Anat. Embryol. 193, 303-318 (1996).
43. Duffield, J. S. & Humphreys, B. D. Origin of new cells in the adult kidney: results from genetic labeling techniques. Kidney. Int. 79, 494-501 (2011).
44. Madisen, L. et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133-140 (2010).
45. Wenger, R. H., Stiehl, D. P. & Camenisch, G. Integration of oxygen signaling at the consensus HRE. Science's STKE, re12 (2005).
46. Frede, S., Freitag, P., Geuting, L., Konietzny, R. & Fandrey, J. Oxygen-regulated expression of the erythropoietin gene in the human renal cell line REPC. Blood 117, 4905-4914 (2011).
47. Mimura, I. et al. Dynamic change of the chromatin conformation in response to hypoxia enhances the expression of GLUT3 (SLC2A3) by cooperative interaction of HIF1 and KDM3A. Mol. Cell. Biol. 32, 3018-3032 (2012).
48. Wang, C. F. et al. Differential gene expression of aldolase C (ALDOC) and hypoxic adaptation in chickens. Anim. Genet. 38, 203-210 (2007).
49. Kapitsinou, P. P. et al. Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia. Blood 116, 3039-3048 (2010).
50. Scortegagna, M. et al. HIF-2alpha regulates murine hematopoietic development in an erythropoietin-dependent manner. Blood 105, 3133-3140 (2005).
51. Liu, Y. et al. Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo. Blood 108, 123-133 (2006).
52. Suzuki, N. et al. Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality. Blood 100, 2279-2288 (2002).
53. Alnaeeli, M. et al. Erythropoietin in brain development and beyond. Anat. Res. Int. 2012, 953264 (2012).
54. Paliege, A. et al. Hypoxia-inducible factor-2alpha-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxiainducible factor stabilization. Kidney. Int. 77, 312-318 (2010).
55. Brandt, W. et al. Defining the functional boundaries of the Gata2 locus by rescue with a linked bacterial artificial chromosome transgene. J. Biol. Chem. 283, 8976-8983 (2008).
56. Golde, W. T., Gollobin, P. & Rodriguez, L. L. A rapid, simple, and humane method for submandibular bleeding of mice using a lancet. Lab. Anim. 34, 39-43 (2005).
57. Yamazaki, H., Katsuoka, F., Motohashi, H., Engel, J. D. & Yamamoto, M. Embryonic lethality and fetal liver apoptosis in mice lacking all three small Maf proteins. Mol. Cell. Biol. 32, 808-816 (2012).
58. Jochum, W. et al. Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat. Med. 6, 980-984 (2000).